|
Prekallikrein
|
D12.776.811.243.658 |
|
|
MELAS Syndrome
|
C10.228.140.163.100.535 |
|
|
Potassium Permanganate
|
D01.530.700 |
|
|
Manganese Compounds
|
D01.530 |
|
|
Equivalence Trials as Topic
|
D000074099 |
[Works about trials that aim to show a new treatment is no better and no worse than the standard treatment.
, Works about trials that aim to show a new treatment is no more effective than the standard treatment.
, Works about trials that aim to show a new treatment is no less effective than the standard treatment.
] |
|
Benzoin
|
D02.522.120.100 |
|
|
Primary Ovarian Insufficiency
|
C19.391.630.750 |
|
|
Ovarian Diseases
|
C19.391.630 |
|
|
Fenretinide
|
D02.455.426.392.368.367.379.249.700.270 |
|
|
Sclerostomy
|
E04.579.895 |
|
|
Receptor, Cholecystokinin A
|
D12.776.543.750.750.555.270.100 |
|
|
Clavibacter
|
B03.510.024.232 |
|
|
Heart Failure, Diastolic
|
C14.280.434.611 |
|
|
War-Related Injuries
|
I01.880.735.950.500.951.500 |
|
|
War Exposure
|
I01.880.735.950.500.951 |
|
|
Menkes Kinky Hair Syndrome
|
C10.228.140.163.100.540 |
|
|
MERRF Syndrome
|
C10.228.140.163.100.545 |
|
|
Excitatory Amino Acid Transporter 3
|
D12.776.157.530.937.250.500.875 |
|
|
Myoclonic Epilepsy, Juvenile
|
C10.228.140.490.375.130.670 |
|
|
Epilepsies, Myoclonic
|
C10.228.140.490.375.130 |
|
